AMN Healthcare stock hits 52-week low at $22.46 amid market shifts

Published 03/04/2025, 15:50
AMN Healthcare stock hits 52-week low at $22.46 amid market shifts

In a challenging market environment, AMN Healthcare Services Inc (NYSE:AMN). stock has touched a 52-week low, with shares falling to $22.46. According to InvestingPro data, the company’s market capitalization stands at $850 million, with an EBITDA of $294 million in the last twelve months. The healthcare staffing company, which has been navigating through a turbulent economic landscape, has seen a significant decline over the past year. Investors have been cautious as the stock’s value has plummeted, marking a stark 1-year change with a decrease of 61.75%. Despite current challenges, InvestingPro analysis suggests the stock is undervalued, with analysts expecting the company to return to profitability this year. This downturn reflects broader sectoral pressures and possibly company-specific headwinds, leading to a cautious outlook among shareholders as they monitor AMN’s performance for signs of a rebound. The company maintains a strong free cash flow yield, and InvestingPro subscribers can access additional insights through the comprehensive Pro Research Report, available for over 1,400 US stocks.

In other recent news, AMN Healthcare Services Inc. reported fourth-quarter revenues of $734.7 million, surpassing both JMP Securities’ projection of $691.0 million and the consensus estimate of $694.4 million, despite a 10% year-over-year decline. The company’s adjusted EBITDA for the quarter was $75.1 million, showing a 28% decrease from the previous year but still exceeding expectations. JMP Securities revised its price target for AMN Healthcare to $33 from $34 while maintaining a Market Outperform rating, reflecting confidence in the company’s future performance. UBS analysts maintained a Neutral rating with a $30 price target, emphasizing the company’s ongoing focus on debt reduction. AMN Healthcare has made significant progress in managing its leverage, ending 2024 with a ratio of 3.0x. Benchmark analysts reiterated a Hold rating, noting stabilizing trends in travel nurse utilization and bill rates as the company enters 2025. The firm highlighted AMN Healthcare’s positive fourth-quarter results, which were bolstered by higher-than-expected strike revenue. Analysts continue to monitor the company’s performance amid evolving industry conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.